Investors & Media
Overview
GENFIT is a biopharmaceutical group conducting late stage clinical trials dedicated to improving the lives of patients with liver diseases with high unmet medical needs, with a special focus on rare, severe and acute pathologies.
Stock Information
Upcoming Events
May 14, 2024
May 22, 2024
September 19, 2024